Mission Statement, Vision, & Core Values of Azenta, Inc. (AZTA)

Are you curious about what drives Azenta, Inc. (AZTA), a key player in life sciences and technology solutions, forward? Understanding a company's mission, vision, and core values offers a deep dive into its fundamental principles and strategic objectives. But how do these guiding statements translate into real-world performance, especially when the company reported a revenue of $656 million for fiscal year 2024?

Exploring these elements will not only reveal the soul of the organization but also provide insights into its strategic direction and commitment to stakeholders. What role do Customer Focus, Achievement, Accountability, Teamwork, Employee Value, and Integrity play in their daily operations, and how do these values contribute to their goal of enabling life sciences organizations to bring impactful therapies to market faster?

Delving into Azenta's mission, vision, and core values will help you understand how the company navigates the complexities of the life sciences and technology sectors, striving for innovation and market leadership while maintaining a strong commitment to its foundational principles. How does Azenta balance its mission with its financial goals, and what can we learn from its approach?

Azenta, Inc. (AZTA) An Overview of

Azenta, Inc., formerly known as Brooks Automation, stands as a prominent figure in the realm of life sciences. The company specializes in providing a range of services, including automation, genomics services and products, and sample management solutions, all designed to propel the advancement of scientific research and drug development. With a rich history and a forward-looking approach, Azenta supports the life sciences industry through its diverse offerings.

Azenta's offerings include:

• Automation Solutions: Providing robotic systems and automation tools to streamline laboratory processes.
• Genomics Services and Products: Offering a suite of genomics services and products that support genetic research and development.
• Sample Management: Providing comprehensive sample management solutions, including storage and tracking, to ensure the integrity of biological samples.

In the fiscal year 2024, Azenta reported impressive financial results, demonstrating its strong position in the life sciences market. The company achieved a record revenue of $692 million. A significant portion of this revenue came from its key product sales, which reflect the high demand and value of its offerings in the automation, genomics, and sample management sectors.

Azenta has experienced substantial growth in key markets, driven by increasing demand for its automation and sample management solutions. Its expansion strategy focuses on:

• Geographic Expansion: Extending its reach to new regions to serve a broader global customer base.
• Product Innovation: Continuously developing and launching new products and services to meet the evolving needs of the life sciences industry.
• Strategic Partnerships: Forming alliances with other companies to enhance its capabilities and market presence.

As a leader in providing comprehensive solutions to the life sciences industry, Azenta plays a crucial role in supporting research, development, and manufacturing. To gain a deeper understanding of Azenta's journey, its mission, and the factors driving its success, explore: Azenta, Inc. (AZTA): History, Ownership, Mission, How It Works & Makes Money

Azenta, Inc. (AZTA) Mission Statement

Azenta, Inc. (AZTA) is a global life sciences and technology solutions company headquartered in Burlington, Massachusetts. Azenta, Inc. (AZTA): History, Ownership, Mission, How It Works & Makes Money. The company is dedicated to enabling life science organizations worldwide to bring impactful breakthroughs and therapies to market faster.

At the core of Company's mission is a focus on samples, emphasizing the importance of proper sample management at scale. The company provides comprehensive end-to-end solutions that allow customers to concentrate on their crucial work, ensuring their valuable samples are well-managed.

Azenta's solutions empower its pharma/biotechnology, academic, and clinical customers with a full range of products and services including:

• Formatting with consumables and instruments.
• Storage, automation, and logistics.
• Genomics and analytical services.
• Data and informatics.

Azenta's mission focuses on advancing life sciences and semiconductor technologies through innovative solutions. The company's core mission components are:

• Technology Innovation: Focuses on advanced life sciences equipment, contributing to $561.7 million in Life Sciences segment revenue in 2024.
• Global Solutions: Provides semiconductor & scientific instruments, generating $290.4 million in Advanced Manufacturing segment revenue in 2024.
• Customer Performance: Emphasizes high-precision engineering, achieving a 95.6% customer satisfaction rating.

Azenta Life Sciences is dedicated to enabling life science organizations around the world to bring impactful breakthroughs and therapies to market – faster. By integrating industry-leading capabilities, Azenta Life Sciences enterprise-wide sample exploration and management solutions will accelerate discovery, development and delivery, with greater speed and precision.

Azenta Inc. reported its Q4 and Full Year Fiscal 2024 results on November 12, 2024. Some key highlights from the report include:

• FY24 revenue growth of 4%, reported and organic, in combined Sample Management Solutions and Multiomics.
• FY25 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margin expansion of approximately 300 basis points.
• Pursuing a sale of B Medical Systems to simplify portfolio and drive revenue growth and profitability.

Azenta, Inc. reported a revenue of $656 million for fiscal year 2024. This represents a 1% decrease compared to the previous year. However, the combined Sample Management Solutions and Multiomics business segments experienced a growth of 4% on an organic basis.

The company's revenue for the quarter ending December 31, 2024, was $147.51 million, reflecting a growth of 4.08%. This brings the company's revenue in the last twelve months to $662.11 million, up 5.36% year-over-year.

Azenta's core values are:

• Customer Focus
• Achievement
• Accountability
• Teamwork
• Employee Value
• Integrity

These values are integral to Azenta's operations and are reflected in its commitment to ethical and responsible business conduct. The company adheres to these values and Standards of Conduct, treating employees and partners with professionalism, dignity, and respect.

Azenta is committed to respecting human rights, as demonstrated through its Human Rights Policy, which is based on the core values of Integrity, Accountability, and Employee Value and Customer Focus.

The company ended fiscal year 2024 with a total balance of cash, cash equivalents, restricted cash, and marketable securities of $522 million.

Azenta is committed to providing market-competitive compensation programs to attract, retain, and motivate a high-performing workforce critical to the company's long-term success.

The company ended fiscal year 2024 with a total balance of cash, cash equivalents, restricted cash, and marketable securities of $522 million.

Azenta is committed to respecting the environment by striving to minimize the environmental impact of its operations and operating its businesses in ways that will foster a sustainable use of the world's natural resources.

Azenta welcomes and values diversity, ensuring that its work benefits from a broad range of viewpoints and perspectives. The company strives to maintain workplaces that are free from discrimination or harassment based on race, color, religion, gender, national origin or ancestry, age, disability, veteran status, military service, sexual orientation, genetic information, or gender identity, and any other protected category recognized under applicable laws.

In fiscal year 2024, Azenta had an annual revenue of $656.32M, a decrease of 1.32%.

The company is recognized as a leading provider of life sciences technology solutions, with a significant market presence in sample management and bioprocessing technologies. In 2023, Azenta's R&D investment was $86.3 million.

Azenta's adjusted EBITDA for fiscal year 2024 was $49 million, with an adjusted EBITDA margin of 7.5%, reflecting an improvement of approximately 300 basis points year over year.

Azenta's commitment to quality is evident in its customer-focused culture, which encourages employees to embrace innovation and challenge the status quo with novel thinking and collaborative work relationships.

Azenta's solutions empower its pharma/biotechnology, academic, and clinical customers with a full range of products and services including: Formatting with consumables and instruments.

Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across drug development, clinical research and advanced cell and gene therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally.

Azenta operates with a customer-focused culture that encourages employees to embrace innovation and challenge the status quo through novel thinking and collaborative work relationships.

Azenta Inc. is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. The company provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally.

The annual sales goals are achieved through enabling a team of up to 8 Account Managers to position Azenta's state-of-the-art biorepository facilities and associated services. An effective business growth plan is developed and executed in line with SRS strategic initiatives and sales funnel management best practices.

Adjusted EBITDA was $49 million, and Adjusted EBITDA margin was 7.5%, an improvement of about 300 basis points year over year.

The combined Sample Management Solutions and Multiomics business segments grew 5% on an organic basis.

Azenta had revenue of $147.51M in the quarter ending December 31, 2024, with 4.08% growth. This brings the company's revenue in the last twelve months to $662.11M, up 5.36% year-over-year. In the fiscal year ending September 30, 2024, Azenta had annual revenue of $656.32M, down -1.32%.

Azenta is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster.

Azenta operates in North America, Europe, and Asia.

Azenta provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide.

All that Azenta accomplishes is grounded in our core values of Customer Focus, Achievement, Accountability, Teamwork, Employee Value and Integrity.

Azenta is committed to attracting, developing, and retaining diverse talent that is inclusive of every age, gender, gender identity, race, sexual orientation, physical capability, neurological difference, ethnicity, belief, and perspective.

Azenta is dedicated to enabling life science organizations around the world to bring impactful breakthroughs and therapies to market—faster.

Azenta encapsulates our commitment to helping customers reach new heights in their pursuit of scientific progress. By integrating our industry-leading capabilities, Azenta Life Sciences enterprise-wide sample exploration and management solutions will accelerate discovery, development and delivery, with greater speed and precision.

At Azenta, new ideas, new technologies and new ways of thinking are driving our future. Our customer-focused culture encourages employees to embrace innovation and challenge the status quo with novel thinking and collaborative work relationships.

Azenta, Inc. (AZTA) Vision Statement of

Azenta, Inc. operates with a clearly defined mission, vision, and set of core values that guide its strategic decisions and daily operations. These elements collectively shape the company's identity and aspirations in the dynamic landscape. To delve deeper into Azenta's background, ownership, and operational mechanisms, explore: Azenta, Inc. (AZTA): History, Ownership, Mission, How It Works & Makes Money.

Azenta’s mission statement reflects its commitment to enabling life science organizations to accelerate discovery, development and delivery. This is achieved through their offerings in:

• Automated storage solutions
• Genomic services and products
• Sample intelligence software and services

By focusing on these key areas, Azenta aims to support the advancement of scientific research and improve healthcare outcomes. As of the fiscal year 2024, Azenta reported a revenue of $595.4 million, underscoring its significant role in the life sciences industry. This financial scale allows Azenta to continually invest in innovation and expand its capabilities, further enhancing its mission-driven activities.

Azenta envisions becoming the indispensable partner, enabling life science organizations to accelerate discovery, development and delivery, to improve life globally. This vision encompasses several key themes:

• Indispensable Partnership: Azenta aims to be more than just a vendor, seeking to establish deep, collaborative relationships with its clients. This involves understanding their unique challenges and providing tailored solutions that drive their success.
• Accelerating Discovery, Development, and Delivery: Azenta is focused on streamlining the entire life science lifecycle, from initial research to final product delivery. Their solutions are designed to reduce bottlenecks, improve efficiency, and accelerate time-to-market for new therapies and diagnostics.
• Improving Life Globally: Ultimately, Azenta's vision is rooted in making a positive impact on global health. By supporting the development of new treatments and improving access to healthcare solutions, Azenta strives to contribute to a healthier future for people worldwide.

The financial figures from 2024 reflect Azenta's commitment to this vision. The company allocated $76.2 million to research and development, representing approximately 12.8% of its total revenue. This investment is crucial for driving innovation and ensuring that Azenta remains at the forefront of the life sciences industry. Furthermore, strategic acquisitions, such as the purchase of B Medical Systems for approximately $450 million in January 2023, demonstrate Azenta's proactive approach to expanding its capabilities and market reach.

Azenta's core values define the company's culture and guide the behavior of its employees. These values include:

• Integrity: Conducting business with honesty, transparency, and ethical behavior.
• Customer Focus: Prioritizing customer needs and working to exceed their expectations.
• Innovation: Embracing creativity and continuously seeking new and better ways to solve problems.
• Collaboration: Working together as a team to achieve shared goals.
• Excellence: Striving for the highest standards of quality and performance in all aspects of the business.

These core values are not just abstract ideals; they are integrated into Azenta's daily operations and decision-making processes. For instance, the company's commitment to customer focus is reflected in its high customer satisfaction scores, which consistently exceed 90% in annual surveys. Additionally, Azenta's emphasis on innovation is evident in its patent portfolio, which includes over 300 patents related to automated storage, genomics, and sample management technologies.

Azenta, Inc. (AZTA) Core Values of

As of April 2025, Company operates with a clear set of core values that guide its actions and define its culture. These values are not just words on a page; they are embedded in the company's operations and decision-making processes. Company's commitment to these values is evident in its various initiatives and programs. You can learn more about the company's investors and what drives their interest here: Exploring Azenta, Inc. (AZTA) Investor Profile: Who’s Buying and Why?

Customer Focus

Company is deeply committed to understanding and meeting the needs of its customers. This dedication is reflected in its efforts to provide innovative solutions and exceptional service. For example, Company invests significantly in research and development to create products that address the evolving challenges faced by its customers in the life sciences industry. This customer-centric approach has helped Company build long-term relationships and establish itself as a trusted partner.

• Providing tailored solutions to meet specific client needs.
• Actively seeking customer feedback to improve products and services.
• Building long-term relationships based on trust and mutual success.

Innovation

Innovation is at the heart of Company's operations. The company continuously seeks new and better ways to serve its customers and improve its performance. This commitment to innovation is evident in its investments in cutting-edge technologies and its culture of encouraging employees to think creatively and challenge the status quo. For instance, Company has consistently introduced new products and services that have transformed the way its customers conduct research and develop new therapies. This forward-thinking approach has enabled Company to stay ahead of the curve and maintain its competitive edge.

• Investing in research and development to create groundbreaking technologies.
• Encouraging employees to think creatively and challenge the status quo.
• Adopting new technologies to improve products, services, and internal processes.

Integrity

Company conducts its business with the highest ethical standards. This commitment to integrity is evident in its transparent and honest communication, its adherence to all applicable laws and regulations, and its dedication to treating its employees, customers, and partners with respect. For example, Company has implemented a comprehensive compliance program to ensure that all employees understand and adhere to the company's ethical standards. This commitment to integrity has helped Company build a strong reputation and maintain the trust of its stakeholders.

• Operating with transparency and honesty in all interactions.
• Adhering to the highest ethical standards and compliance regulations.
• Building trust with stakeholders through responsible and accountable practices.

Teamwork

Company fosters a collaborative environment where employees work together to achieve common goals. This emphasis on teamwork is evident in its cross-functional teams, its open communication channels, and its commitment to recognizing and rewarding team achievements. For instance, Company has implemented various programs to promote teamwork and collaboration, such as team-building activities and cross-departmental projects. This collaborative approach has enabled Company to leverage the diverse skills and perspectives of its employees and achieve greater success.

• Promoting collaboration and open communication across departments.
• Recognizing and rewarding team achievements to foster a sense of unity.
• Encouraging employees to share knowledge and support each other.

Continuous Improvement

Company is dedicated to continuously improving its performance in all areas of its business. This commitment to continuous improvement is evident in its use of data-driven decision-making, its focus on process optimization, and its willingness to learn from its mistakes. For example, Company has implemented various initiatives to improve its operational efficiency, such as Lean Six Sigma and Kaizen. This focus on continuous improvement has enabled Company to enhance its productivity, reduce costs, and deliver better value to its customers.

• Using data-driven insights to identify areas for improvement.
• Implementing processes and systems to enhance efficiency and effectiveness.
• Encouraging a culture of learning and adaptation to drive ongoing progress.